European Archives - Page 620 of 809 - European Medical Journal

Continue
7 Mins
5th April 2017

RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma

Tel-Aviv, Israel, April 04, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty…
3 Mins
5th April 2017

Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets

Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million…
2 Mins
5th April 2017

Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia –The MIND-MAPS Study

London, UK, April 03, 2017 – Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography (PET) imaging tracers…
3 Mins
5th April 2017

ELCC 2017: Latest News in Lung Cancer

Geneva, Switzerland, May 5-8 2017 – Around 2,000 delegates from across Europe and worldwide will learn about the latest practice-changing science in the…
1 Mins
5th April 2017

Low Vitamin D Levels Linked to Ulcerative Colitis Relapse

CLINICAL relapse risk amongst individuals with ulcerative colitis (UC) more common if the levels of vitamin D in the blood are lower than required…
1 Mins
5th April 2017

Connection Uncovered Between Gut Bacteria and Patient Behaviour

A POTENTIAL link has been discerned between gut bacteria and behaviour in patients with irritable bowel syndrome (IBS), a common gastrointestinal…
1 Mins
31st March 2017

This March, EMJ Supports

This March, EMJ has proudly showcased its support for an assortment of medical campaigns including: Ovarian Cancer Awareness Month, World Kidney Day…
3 Mins
31st March 2017

Revolutionising Digital Healthcare within the National Health Service

The National Health Service (NHS) in the UK is set to introduce major changes to the NHS Choices website in the following months, after an increased…
2 Mins
28th March 2017

Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24

Krakow, Poland / Berlin, Germany, March 28, 2017 – Selvita S.A. (WSE:SLV), and Berlin-Chemie Menarini, a company of the Menarini Group, announced today…
1 Mins
27th March 2017

Focussed Ultrasound for Tumour Destruction

FOCUSSED ultrasound has been suggested as a future therapy for the gentler treatment of tumours of the liver. Already used readily as a diagnostic method…